Anti-oral Squamous Cell Carcinoma Effects of a Potent TAZ Inhibitor AR-42

Oral squamous cell carcinoma (OSCC) is one of the most common malignancies worldwide. Although great progress has been made in diagnosis and treatment strategies in recent years, the 5-year survival rate of OSCC patients is still disappointingly low. Hence, there is still an unmet medical need for s...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Lingyu, Wang, Si, Yuan, Ting, Xie, Xudong, Fu, Xiaoming, Ji, Ping, Zhong, Lei, Liu, Wenzhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930442/
https://www.ncbi.nlm.nih.gov/pubmed/31897232
http://dx.doi.org/10.7150/jca.32436

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930442/
https://www.ncbi.nlm.nih.gov/pubmed/31897232
http://dx.doi.org/10.7150/jca.32436

Ejemplares similares